Title : Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4\/nuclear factor-kappa B pathway - Cakir_2023_Int.Immunopharmacol_114_109586 |
Author(s) : Cakir M , Aydin A , Tekin S |
Ref : Int Immunopharmacol , 114 :109586 , 2023 |
Abstract : Cakir_2023_Int.Immunopharmacol_114_109586 |
ESTHER : Cakir_2023_Int.Immunopharmacol_114_109586 |
PubMedSearch : Cakir_2023_Int.Immunopharmacol_114_109586 |
PubMedID: 36700769 |
Title : Bioactivity and molecular docking studies of some nickel complexes: New analogues for the treatment of Alzheimer, glaucoma and epileptic diseases - Kisa_2020_Bioorg.Chem_101_104066 |
Author(s) : Kisa D , Korkmaz N , Taslimi P , Tuzun B , Tekin S , Karadag A , Sen F |
Ref : Bioorg Chem , 101 :104066 , 2020 |
Abstract : Kisa_2020_Bioorg.Chem_101_104066 |
ESTHER : Kisa_2020_Bioorg.Chem_101_104066 |
PubMedSearch : Kisa_2020_Bioorg.Chem_101_104066 |
PubMedID: 32650180 |
Title : Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch - Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
Author(s) : Sadowsky C , Perez JA , Bouchard RW , Goodman I , Tekin S |
Ref : CNS Neurosci Ther , 16 :51 , 2010 |
Abstract : Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
ESTHER : Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
PubMedSearch : Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
PubMedID: 20070789 |
Title : Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias - Ballard_2006_Int.J.Clin.Pract_60_639 |
Author(s) : Ballard C , Lane R , Barone P , Ferrara R , Tekin S |
Ref : Int J Clin Pract , 60 :639 , 2006 |
Abstract : Ballard_2006_Int.J.Clin.Pract_60_639 |
ESTHER : Ballard_2006_Int.J.Clin.Pract_60_639 |
PubMedSearch : Ballard_2006_Int.J.Clin.Pract_60_639 |
PubMedID: 16805745 |
Title : Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study - Poewe_2006_Mov.Disord_21_456 |
Author(s) : Poewe W , Wolters E , Emre M , Onofrj M , Hsu C , Tekin S , Lane R |
Ref : Movement Disordersord , 21 :456 , 2006 |
Abstract : Poewe_2006_Mov.Disord_21_456 |
ESTHER : Poewe_2006_Mov.Disord_21_456 |
PubMedSearch : Poewe_2006_Mov.Disord_21_456 |
PubMedID: 16229010 |
Title : Rivastigmine for dementia associated with Parkinson's disease - Emre_2004_N.Engl.J.Med_351_2509 |
Author(s) : Emre M , Aarsland D , Albanese A , Byrne EJ , Deuschl G , De Deyn PP , Durif F , Kulisevsky J , van Laar T , Lees A , Poewe W , Robillard A , Rosa MM , Wolters E , Quarg P , Tekin S , Lane R |
Ref : N Engl J Med , 351 :2509 , 2004 |
Abstract : Emre_2004_N.Engl.J.Med_351_2509 |
ESTHER : Emre_2004_N.Engl.J.Med_351_2509 |
PubMedSearch : Emre_2004_N.Engl.J.Med_351_2509 |
PubMedID: 15590953 |